欢迎光临金融市场技术研究院
微信公众号
投资群
读书群
文章
文章
报告
图书
公募
私募
资讯
搜 索
上传文档
首页
文章
报告
图书
公募
私募
资讯
金融终端
您的当前位置:
首页
>
研究报告
>
外盘报告
> 预览报告
20170825-中国银河国际证券-联邦制药-03933.HK-Insulin slowed down, 6-APA positives reflected. Maintain HOLD..pdf
报告类型:港股公司研究
页数:5
文件大小:573K
上传时间:2026-05-20
机构:中国银河国际证券
作者:Harry He
0阅读
0收藏
0下载
下载PDF
所需积分:1
如何获取K积分
下载PDF
下载全文所需积分:1
网友评论
{{Creator}}
{{Body}}
{{$val.TimeAgo({Dtime})}}
[回复]
{{Creator}}
:
回复
{{BeQuote}}
{{Body}}
{{$val.TimeAgo({Dtime})}}
[回复]
上传用户
文章
0
报告
0
图书
0
相关报告
20170831-汇丰银行-银河娱乐-00027.HK-Buy: 2Q17 beat on margin and construction business.pdf
20170824-中国银河国际证券-昂纳科技集团-00877.HK-Revitalizing in 2H 2017.pdf
20170824-中国银河国际证券-伟仕佳杰-00856.HK-1H 2017 Results remains solid. Maintain BUY.pdf
20170831-中银证券-昆仑能源-00135.HK-最后的隐忧解除.pdf
20170822-中国银河国际证券-理文造纸-02314.HK-In-line 1H 2017 Results. Tissue paper remains a growth driver.pdf
20170828-中国银河国际证券-彩生活-01778.HK-Earnings improved but potential yet to be released: Maintain BUY.pdf
20170829-中国银河国际证券-成实外教育-01565.HK-Virscend Education Interim Results.pdf
20170828-中国银河国际证券-瑞声科技-02018.HK-Concerns about Q2 results put to rest. Optics business development will trigger a further re-rat
20170830-中国银河国际证券-上海实业控股-00363.HK-NEED MORE CONCRETE ACTION TO UNLOCK VALUE.pdf
20170825-中国银河国际证券-中兴通讯-00763.HK-1H 2017 Results In Line With Expectations. Maintain BUY..pdf
{"InnerBanner":null,"MbPageUrl":"/m/Datums/Report?id=6639861","PageTitle":"20170825-中国银河国际证券-联邦制药-03933.HK-Insulin slowed down, 6-APA positives reflected. Maintain HOLD..pdf-外盘报告 - 研究报告","Redirect":null,"Data":{"Uploader":{"ID":79,"Face":"/_files/face/0/lcd8pzhc.jpg","UName":"虎翰海","UpArts":0,"UpRpts":24735,"UpLbies":23},"Rid":6639861,"IsPdf":false,"IsExist":false,"PdfUrl":"/download2.mtachn.com/upload/report/外盘报告/20170825-中国银河国际证券-联邦制药-03933.HK-Insulin slowed down, 6-APA positives reflected. Maint","RePage":-1},"UserInfo":{"ID":0,"UName":null,"Face":null}}